Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL284364 | 1.00 | — | — | |
| SCHEMBL9909079 | 1.00 | ALDH1A1 (0.38) | ALDH1A1TDP1TSHRCYP2C19 | |
| SCHEMBL8919 | 1.00 | — | — | |
| SCHEMBL8424624 | 1.00 | ALDH1A1 (0.38) | ALDH1A1TDP1TSHRCYP2C19 | |
| SCHEMBL22448471 | 1.00 | ALDH1A1 (0.38) | ALDH1A1TDP1TSHRCYP2C19 | |
| SCHEMBL24054976 | 1.00 | ALDH1A1 (0.38) | ALDH1A1TDP1TSHRCYP2C19 | |
| SCHEMBL13122851 | 1.00 | ALDH1A1 (0.38) | ALDH1A1TDP1TSHRCYP2C19 | |
| SCHEMBL10274898 | 1.00 | ALDH1A1 (0.38) | ALDH1A1TDP1TSHRCYP2C19 | |
| SCHEMBL21120437 | 1.00 | ALDH1A1 (0.38) | ALDH1A1TDP1TSHRCYP2C19 | |
| SCHEMBL12094717 | 1.00 | ALDH1A1 (0.38) | ALDH1A1TDP1TSHRCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024084450-A1 | BICYCLIC HETEROARYL COMPOUNDS AND THEIR DERIVATIVES AS PKMYT1 INHIBITORS | AURIGENE ONCOLOGY LIMITED (IN) | 2024-04-25 | — | — | WO | disclosed |
| WO-2024043098-A1 | RESIST COMPOSITION, RESIST PATTERN FORMING METHOD, COMPOUND, AND INTERMEDIATE THEREOF | 東京応化工業株式会社 | 2024-02-29 | — | — | WO | disclosed |
| WO-2023171527-A1 | RESIST COMPOSITION AND METHOD FOR FORMING RESIST PATTERN | 東京応化工業株式会社 | 2023-09-14 | — | — | WO | disclosed |
| WO-2023162907-A1 | RESIST COMPOSITION, RESIST PATTERN FORMATION METHOD, COMPOUND, AND ACID GENERATION AGENT | 東京応化工業株式会社 | 2023-08-31 | — | — | WO | disclosed |
| WO-2023145923-A1 | RESIST UNDERLAYER FILM FORMING COMPOSITION FOR NANOIMPRINTING | 日産化学株式会社 | 2023-08-03 | — | — | WO | disclosed |
| WO-2023140386-A1 | RESIST COMPOSITION AND METHOD FOR FORMING RESIST PATTERN | 東京応化工業株式会社 | 2023-07-27 | — | — | WO | disclosed |
| US-11616119-B2 | Integrated assemblies and methods forming integrated assemblies | MICRON TECHNOLOGY, INC. (US) | 2023-03-28 | — | — | US | disclosed |
| WO-2023013592-A1 | RESIST COMPOSITION AND METHOD FOR FORMING RESIST PATTERN | 東京応化工業株式会社 | 2023-02-09 | — | — | WO | disclosed |
| US-20220016613-A1 | NOVEL ANNULATION CATALYSTS VIA DIRECT C-H BOND AMINATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-01-20 | — | — | US | disclosed |
| EP-3913577-A1 | GERMANIUM-SILICON LIGHT SENSING APPARATUS | Artilux Inc. (US) | 2021-11-24 | — | — | EP | disclosed |
| WO-2009027820-A2 | SUBSTITUTED-QUINOXALINE-TYPE-PIPERIDINE COMPOUNDS AND THE USES THEREOF | PURDUE PHARMA L.P. (DE) | 2009-03-05 | — | — | WO | disclosed |
| WO-2009027820-A2 | SUBSTITUTED-QUINOXALINE-TYPE-PIPERIDINE COMPOUNDS AND THE USES THEREOF | PURDUE PHARMA L.P. (DE) | 2009-03-05 | — | — | WO | disclosed |
| EP-0206621-B1 | PROCESS FOR DISPROPORTIONATING SILANES | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1989-11-15 | — | — | EP | disclosed |
| US-4754077-A | HINDERED PHENOLS, METHANOL, FORMALDEHYDE, PHENOL COMPOUND, MANNICH BASE CATALYST | ETHYL CORPORATION (US) | 1988-06-28 | — | — | US | disclosed |
| US-4692555-A | Preparation of diphenolics | ETHYL CORPORATION (US) | 1987-09-08 | — | — | US | disclosed |
| EP-0116712-B1 | SYNTHESIS OF HINDERED PHENOLS | ETHYL CORPORATION (US) | 1987-03-25 | — | — | EP | disclosed |
| EP-0206621-A1 | Process for disproportionating silanes | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1986-12-30 | — | — | EP | disclosed |
| EP-0116712-A1 | Synthesis of hindered phenols | ETHYL CORPORATION (US) | 1984-08-29 | — | — | EP | disclosed |
| WO-1984002336-A1 | ANTIOXIDANT SYNTHESIS | ETHYL CORP (US) | 1984-06-21 | — | — | WO | disclosed |
| US-4194008-A | INSECTICIDE, FUNGICIDE, MITICIDE, PARASITICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1980-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220016613-A1 | NOVEL ANNULATION CATALYSTS VIA DIRECT C-H BOND AMINATION | AADAC, CAD, AOC1 | ALDH1A1 435/4885TDP1 4113/4885TSHR 2722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.